Physician profile
Daniel Hettel
NPI 1285124636
$3,486.82
in general payments reported to CMS, 2019-2025
10 companies · $2,767 in 2025
The $2,767 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $207 · 2023: $297 · 2024: $102 · 2025: $2,767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,568 · Travel and Lodging: $899 · Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,568.00 |
| Travel and Lodging | $898.82 |
| Food and Beverage | $698.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,546.36 | 2023-2025 | |
| Medtronic, INC. | $256.09 | 2023-2024 | Interstim |
| Boston Scientific Corporation | $254.39 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $123.08 | 2025 | Gemtesa |
| Baxter Healthcare | $114.54 | 2021 | |
| Janssen Biotech, INC. | $81.69 | 2025 | Erleada, Rybrevant |
| Astellas Pharma US INC | $42.03 | 2024-2025 | Xtandi |
| Stemline Therapeutics INC. | $31.16 | 2025 | Orserdu |
| Pfizer INC. | $18.76 | 2024 | |
| Myriad Genetic Laboratories, INC. | $18.72 | 2024 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hettel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.